Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1982 |
100 Clinical Results associated with Yabang Pharmaceutical Group Co Ltd
0 Patents (Medical) associated with Yabang Pharmaceutical Group Co Ltd
100 Deals associated with Yabang Pharmaceutical Group Co Ltd
100 Translational Medicine associated with Yabang Pharmaceutical Group Co Ltd